Learn more about optimizing cell therapy products via the Excellos 360 approach.

 

Cell therapies are a paradigm shift in medicine, already demonstrating remarkable results in a variety of indications to date with numerous clinical trials ongoing or planned in the near term. Despite these promising results, this class of therapeutics can be further optimized to garner even greater clinical benefit. 

Some key aspects for further improvement include better characterization of the potency and durability of cells from donors, starting materials, manufacturing intermediates, and final products manufactured. The technologies to enable this, using metabolic and proteomics-based functional evaluations, can be leveraged to improve the cAPI composition of the infused product, resulting in greater clinical benefit to the patient.